Vivo Capital, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $629 Million distributed in 47 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $149M, Terns Pharmaceuticals, Inc. with a value of $52.4M, Trevi Therapeutics, Inc. with a value of $45.5M, Cogent Biosciences, Inc. with a value of $40.1M, and Geron Corp with a value of $37.3M.
Examining the 13F form we can see an increase of $157M in the current position value, from $472M to 629M.
Vivo Capital, LLC is based out at Palo Alto, CA
Below you can find more details about Vivo Capital, LLC portfolio as well as his latest detailed transactions.
